Literature DB >> 18836723

[Urothelial carcinoma. Does surgical pathology learn from molecular pathology?].

F Hofstädter1.   

Abstract

The question is raised whether the new theories about initiation and progression of urothelial carcinoma gained by molecular techniques show effects on the classification and histopathological diagnosis. As fundamental new concepts are considered: two pathways of tumor progression, clonality of synchronous and metachronous tumors, tumor-analogous molecular findings in flat lesions, and stromal invasion as dominant principle of molecular tumor classification.The dual pathogenesis of molecular pathology is reflected by the WHO 2004 classification by the differentiation into low and high grade malignancy, but diluted by the use of PUNLMP (papillary urothelial neoplasia of low malignant potential). The new concept of frequent oligoclonality should induce investigations about the mechanism of propagation of these migrating or metastasizing cells and whether they possess stem cell characteristics. The role of flat urothelial lesions must be revised from a molecular pathological view point, but the histological diagnosis does not gain profit till now. The expression signatures of stromal invasive tumors compared with non-invasive ones points to the major importance of an exact histopathological diagnosis in this area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836723     DOI: 10.1007/s00292-008-1076-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  9 in total

1.  Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.

Authors:  E C Obermann; K Junker; R Stoehr; W Dietmaier; D Zaak; J Schubert; F Hofstaedter; R Knuechel; A Hartmann
Journal:  J Pathol       Date:  2003-01       Impact factor: 7.996

2.  Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.

Authors:  Jorge Martínez-Torrecuadrada; Gabriela Cifuentes; Paula López-Serra; Pilar Saenz; Antonio Martínez; J Ignacio Casal
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

3.  Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.

Authors:  Peter J Wild; Alexander Herr; Christoph Wissmann; Robert Stoehr; Andre Rosenthal; Dirk Zaak; Ronald Simon; Ruth Knuechel; Christian Pilarsky; Arndt Hartmann
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

4.  Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.

Authors:  Isabelle Bernard-Pierrot; Aude Brams; Claire Dunois-Lardé; Aurélie Caillault; Sixtina Gil Diez de Medina; David Cappellen; Gabriel Graff; Jean Paul Thiery; Dominique Chopin; David Ricol; François Radvanyi
Journal:  Carcinogenesis       Date:  2005-12-07       Impact factor: 4.944

5.  Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.

Authors:  Johanna M M van Oers; Christoph Adam; Stefan Denzinger; Robert Stoehr; Simone Bertz; Dirk Zaak; Christian Stief; Ferdinand Hofstaedter; Ellen C Zwarthoff; Theodorus H van der Kwast; Ruth Knuechel; Arndt Hartmann
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

Review 6.  Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

Authors:  Anirban P Mitra; Ram H Datar; Richard J Cote
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

7.  Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.

Authors:  Arndt Hartmann; Gudrun Schlake; Dirk Zaak; Edwin Hungerhuber; Alfons Hofstetter; Ferdinand Hofstaedter; Ruth Knuechel
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

8.  Mapping of the urinary bladder: its impact on the concepts of bladder cancer.

Authors:  L G Koss
Journal:  Hum Pathol       Date:  1979-09       Impact factor: 3.466

Review 9.  Urothelial papillary (exophytic) neoplasms.

Authors:  David G Bostwick; Gregor Mikuz
Journal:  Virchows Arch       Date:  2002-06-13       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.